This federal contract award, with an ID of SPE2DB20D2104|SPE2DB25FMDPQ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price of $5,384.30 and a completion date of December 9, 2024. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/7/25, 10:06 AM